BR0009636B1 - processo para a preparação de insulina madura ou um derivado de insulina madura. - Google Patents

processo para a preparação de insulina madura ou um derivado de insulina madura.

Info

Publication number
BR0009636B1
BR0009636B1 BRPI0009636-9A BR0009636A BR0009636B1 BR 0009636 B1 BR0009636 B1 BR 0009636B1 BR 0009636 A BR0009636 A BR 0009636A BR 0009636 B1 BR0009636 B1 BR 0009636B1
Authority
BR
Brazil
Prior art keywords
carboxypeptidase
mature insulin
derivative
preparation
precursor form
Prior art date
Application number
BRPI0009636-9A
Other languages
English (en)
Other versions
BR0009636A (pt
Inventor
Paul Habermann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0009636A publication Critical patent/BR0009636A/pt
Publication of BR0009636B1 publication Critical patent/BR0009636B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0009636-9A 1999-04-09 2000-03-23 processo para a preparação de insulina madura ou um derivado de insulina madura. BR0009636B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19915938A DE19915938A1 (de) 1999-04-09 1999-04-09 Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
PCT/EP2000/002571 WO2000061727A2 (de) 1999-04-09 2000-03-23 Herstellung von pankreatischer procarboxypeptidase b, isoformen und muteinen davon und ihre verwendung

Publications (2)

Publication Number Publication Date
BR0009636A BR0009636A (pt) 2002-01-08
BR0009636B1 true BR0009636B1 (pt) 2010-11-16

Family

ID=7903951

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0009636-9A BR0009636B1 (pt) 1999-04-09 2000-03-23 processo para a preparação de insulina madura ou um derivado de insulina madura.

Country Status (17)

Country Link
US (1) US6531294B1 (pt)
EP (1) EP1169461B1 (pt)
JP (1) JP2002541793A (pt)
KR (1) KR100714116B1 (pt)
CN (1) CN100362105C (pt)
AT (1) ATE341630T1 (pt)
AU (1) AU777408B2 (pt)
BR (1) BR0009636B1 (pt)
CA (1) CA2369973C (pt)
DE (2) DE19915938A1 (pt)
ES (1) ES2270827T3 (pt)
HK (1) HK1044566B (pt)
IL (2) IL145646A0 (pt)
NO (1) NO326247B1 (pt)
NZ (1) NZ514657A (pt)
WO (1) WO2000061727A2 (pt)
ZA (1) ZA200108241B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
ES2337684T3 (es) * 2003-12-05 2010-04-28 F. Hoffmann-La Roche Ag Carboxipeptidasa b recombinante y su purificacion.
EP1538203B1 (en) * 2003-12-05 2010-01-20 Roche Diagnostics GmbH Recombinantly expressed carboxypeptidase B and purification thereof
JP5114201B2 (ja) * 2004-09-27 2013-01-09 サノフイ−アベンテイス・ドイチユラント・ゲー・エム・ベー・ハー 組み換えカルボキシペプチダーゼｂ
ES2425413T3 (es) * 2006-11-22 2013-10-15 Novo Nordisk A/S Método para preparar carboxipeptidasa activada
CN101058805B (zh) * 2007-03-21 2011-09-07 北京贯虹科技有限公司 突变羧肽酶原b及突变羧肽酶b的生产方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58906966D1 (de) 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
IL95495A (en) 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
JP2660095B2 (ja) * 1989-10-31 1997-10-08 シェリング・コーポレーション 大腸菌分泌性株
DE4009268A1 (de) 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
FI103805B (fi) * 1990-09-05 1999-09-30 Hoechst Ag Menetelmä preproinsuliinien hydroloimiseksi
DE4136389A1 (de) 1991-03-18 1992-10-08 Hoechst Ag Verfahren zur herstellung von glutarylacylase in grossen mengen
CA2175834A1 (en) * 1993-11-16 1995-05-26 Jeffrey Tobin Fayerman Dna sequences encoding porcine pancreatic carboxypeptidase b
US5658755A (en) 1994-07-15 1997-08-19 Eli Lilly And Company Method for extra-cellular expression of protein
IL116696A (en) 1995-01-25 1999-08-17 Bio Technology General Corp Production of enzymatically active recombinant carboxypeptidase b

Also Published As

Publication number Publication date
KR100714116B1 (ko) 2007-05-07
WO2000061727A2 (de) 2000-10-19
CA2369973A1 (en) 2000-10-19
BR0009636A (pt) 2002-01-08
IL145646A0 (en) 2002-06-30
US6531294B1 (en) 2003-03-11
NZ514657A (en) 2003-11-28
WO2000061727A3 (de) 2001-02-01
CN1346407A (zh) 2002-04-24
AU4539400A (en) 2000-11-14
AU777408B2 (en) 2004-10-14
ATE341630T1 (de) 2006-10-15
EP1169461B1 (de) 2006-10-04
DE19915938A1 (de) 2000-10-19
CN100362105C (zh) 2008-01-16
HK1044566A1 (en) 2002-10-25
DE50013563D1 (de) 2006-11-16
EP1169461A2 (de) 2002-01-09
NO20014815L (no) 2001-11-20
JP2002541793A (ja) 2002-12-10
NO20014815D0 (no) 2001-10-03
KR20010109348A (ko) 2001-12-08
HK1044566B (zh) 2008-08-01
CA2369973C (en) 2011-09-27
ES2270827T3 (es) 2007-04-16
IL145646A (en) 2008-03-20
ZA200108241B (en) 2002-11-27
NO326247B1 (no) 2008-10-27

Similar Documents

Publication Publication Date Title
SG2013021217A (en) Production of high mannose proteins in plant culture
AU2575701A (en) Sugarbeet regeneration and transformation
PL322611A1 (en) Methods of obtaining l-amini acid by fermentation, dna as well as micro-organism
YU55100A (sh) Postupak za fermentacionu proizvodnju d-pantotenske kiseline upotrebom bakterija korinskog oblika
ATE314463T1 (de) Maltose-trehalose-konvertierendes enzym, dessen herstellung und verwendung
DE60029091D1 (de) Verfahren zur herstellung von diphtheria toxin
ES2195993T3 (es) Metodo para inhibir la produccion de etileno en plantas.
AU6993698A (en) Preparation of nucleic acids using acid protease
AU2369595A (en) In vitro growth of functional islets of langerhans and in vivo uses thereof
DE69836491D1 (de) Fibrinmikrokugeln und deren verwendungen
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
ES2059498T3 (es) Procedimiento para la produccion de avermectina b y cultivos para ello.
CA2058930A1 (en) Media for cell growth and method for making them
DE60028152D1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher Komplex von Orthokieselsäure und Prozess zur dessen Herstellung
WO2002018361A3 (en) Compounds having activity as inhibitors of cytochrome p450rai
AU3070400A (en) Process for purifying high molecular weight hyaluronic acid
BR0009636B1 (pt) processo para a preparação de insulina madura ou um derivado de insulina madura.
PT775159E (pt) Novo processo de producao de proteina dimerica biologicamente activa
WO1999029279A3 (en) Long-term survival and regeneration of central nervous system neurons
DE3783265D1 (de) Stabilisierte nad(p)h-abhaengige loesliche nitratreduktase, verfahren zu ihrer herstellung und ihre verwendung.
SE9501472D0 (sv) Truncated IGF-I
WO1991006314A3 (en) Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
ES2004099A6 (es) Procedimiento de preparacion de polipeptidos biologicamente activos
EP0955375A3 (en) Method for producing optically active 4-Halo-3-Hydroxybutyric acid ester
WO2003033685A3 (en) Method of producing human beta cell lines

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/11/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: REFERENTE AO DESPACHO 21.6 PUBLICADO NA RPI 2559 DE 2020-01-21